“Bringing the world into focus
through the lens of Scripture”

 

frosty@khouseafrica.com

 

 

 

K-House Africa

 

Banking Details

 

 

 

 Watch us
on You Tube

 

Radio 66/40

 

 

 

 Africa news

 

THE STRUGGLE FOR JERUSALEM

 

 

The Rise Of Islam

 

 

THE DECLINE OF THE USA

 

 

GLOBAL RELIGION

 

 

GLOBAL PESTILENCE

 

 

Global Government

 

 

THE RISE OF THE FAR EAST

 

 

THE RISE OF THE EUROPEAN SUPER STATE

 

 

WEAPONS PROLIFERATION

 

 

THE MAGOG INVASION

 

 

Classics

 

 

UNDERSTAND THE TIMES

 

 

 

Articles

 

DVD PRICELIST

 

Price List

 

 Kings High Way Briefing Packs

 

Topical Teachings

DVD Briefing Back

Packs

 

Audio CD

 

Audio MP3 Collections

 

DVD

 Commentaries

 

Strategic Trends

 

Verse By Verse Commentaries

 

Old Testament Study Notes

 

New Testament Study Notes

 

Personal Update

 

Donations

 

New Product Notice

 

FAQ

 

Contact US

 

K-House USA

 

Comment Line

 

Time Traveller

 

Other Links

 

DEVOTIONAL

 

Words in Red

 

Prophecy News Watch

 

The Coming Prince

 

THE WITNESS 1 Audio MP3

 

THE WITNESS 2 Audio MP3

 

hawk warrior

 

 

 

 

 

 

INTERNATIONAL NEWS FEEDS


 In The News provided by Koinonia House


Best viewed with Internet Explorer.


 

Monitor The Strategic Trends

Biotech & Global Pestilence Introduction:

 

The threat of germ warfare has brought to the forefront long-forgotten diseases like plague, anthrax, and smallpox. Recent television news programs have highlighted secret projects in the former Soviet Union to develop antibiotic-resistant strains of genetically engineered viruses and bacteria.


[READ THE FULL INTRODUCTION]

 

 


 

Human Nature

Speakers:

Ron Matsen

R179.00

 

 

 

About available formats

Description: 

What does it mean to be human? Philosophers, theologians, sociologists and psychologists have attempted to understand the nature of mankind for ages. Their conclusions often contradict each other which lead to confusion rather than clarification. Clearly Man is a very complicated social being. The Bible tells us that man is “fearfully and wonderfully made.”
  • How do we understand our makeup and does it make a difference?
  • What is the meaning of being “created in the image of God?”
  • What causes our natural responses and can we change this behaviour?

Join Ron Matsen from the Executive Briefing Room of the River Lodge, New Zealand as he explores the subject of our “Human Nature” and gives insight into the architecture and accountability of all mankind.

This briefing pack contains approx. 2 hours of teaching.

  • DVD discs
  • M4A files
  • PDF Notes file
  •  

CANCER  Awareness

 

 

Dedicated Page

 

 

 

Price R 179

 

 

***Brand New Release***

 

Beginning of Wisdom

by

 Dr. Chuck Missler

“The fear of God is the beginning of wisdom.” Proverbs 9:10

But how do we balance the awesome majesty due to the Creator and Ruler of the universe with the gracious family intimacy that is now available to us through the completed work of Christ?

What does His Holiness demand of us, personally?

What are the hazards of failing to render the Almighty His due, while availing ourselves the riches committed to us of the precious promises in His Word?

How do we deal with these paramount issues facing us daily in practical challenges?

Chuck Missler grapples with these wildly misunderstood tensions with down-to-earth frankness and Biblically-based candor.

 


 

 

Price R 179.00

 

 

The Gospel: The Message of Reconciliation

DVD

by Ron Matsen 

 

 

 

Price R 179.00

 

 

 

Description

One of the last instructions given by Jesus to the Church was, “Go into all the world and preach the gospel.” (Mark 16:15)

The fact is most Christians don’t know how to share their faith effectively. Sadly, many of the people they know in the world today are wandering around, lost and without hope, having never heard the wonderful Message of Reconciliation.

How would you answer the question, “What must I do to be saved?”

What are the essential facts, demands and promises of the Gospel?

Why are we told to evangelize?

Join Ron Matsen in the Executive Briefing Room of the River Lodge, New Zealand as he explores the subject of “The Gospel – The Message of Reconciliation” and gives practical insight into how to share the essential doctrines of salvation.

This briefing pack contains 2 hours of teaching

© Copyright 2013

Available in the following formats

DVD:

  • 1 Disc

  • 2 M4A Files

  • 1 PDF Notes File

  • Color, Fullscreen 16:9, Dolby Digital 2.0 stereo, Region  (This DVD will be viewable in other countries WITH the proper DVD player and television set.)

 

Earth News, Earth Science, Energy Technology, Environment News

 

NEW DEDICATED PAGE

 

 

Cher-Bang Bang (My Baby Shot Me Down) 1966 Music Video.avi

 

SABC NewsSABC Logo

 

I WILL CURSE THOSE WHO

 

 CURSE THEE'

 

 

THE PERFECT STORM

 
Diseases/Conditions News Headlines - Yahoo! News

 

 

Biogen wins U.S. approval of long acting multiple sclerosis drug

 
‎16 ‎August ‎2014, ‏‎12:52:34 AMGo to full article
By Bill Berkrot NEW YORK (Reuters) - U.S. health regulators on Friday approved Biogen Idec Inc's Plegridy, a long-acting multiple sclerosis drug that the company expects will eventually replace its older big-selling Avonex treatment. Some other MS treatments from the interferon class of medicines, such as Pfizer Inc's Rebif, are dosed more frequently than Avonex. Biogen said it will continue to support Avonex, which has compiled global sales of more than $1.5 billion in the first half of this year, for patients who are comfortable with the treatment and not looking to switch. Avonex has U.S. patent protection until 2026, Biogen said.
 

Extra mastectomy may not extend life for some breast cancer patients

 
‎15 ‎August ‎2014, ‏‎10:35:06 PMGo to full article
By Kathryn Doyle NEW YORK (Reuters Health) - - For some women with early stage breast cancer, removing the healthy breast likely doesn’t afford much of a survival benefit, according to a new study. “A lot of women with cancer in one breast decide to have both breasts removed to try to improve their survival or life expectancy,” said senior author Dr. Todd M. Tuttle, a surgeon at the University of Minnesota in Minneapolis. For some women – such as those at high genetic risk for breast cancer - removing a still-healthy breast may very well help in the long run, Tuttle said. Tuttle and his coauthors used published data to develop a model for predicting survival rates over 20 years for women diagnosed with stage I or II cancer at age 40, 50 or 60.
 

Religiosity associated with less depression in elderly: study

 
‎15 ‎August ‎2014, ‏‎09:47:21 PMGo to full article
By Shereen Lehman NEW YORK (Reuters Health) – - In a study of older adults, religious participation was correlated with better mood. People in the study who often attended religious services were less likely to report symptoms of depression during the two-year study, researchers found. It can’t say, for example, whether people became depressed because they didn’t participate in religious activities, or whether the depression itself was the reason they didn’t participate – or whether something else was at play. “It would be wrong to say ‘religion is good for you’ - this paper is not saying that,” Dr. Gary Kennedy, who directs the Division of Geriatric Psychiatry at Montefiore Medical Center in New York, told Reuters Health by phone.
 

In CDC bird flu mix-up, U.S. agency cites sloppy science, failed reporting

 
‎15 ‎August ‎2014, ‏‎08:18:48 PMGo to full article
The Centers for Disease Control sign is seen at its main facility in AtlantaBy Sharon Begley NEW YORK (Reuters) - A U.S. government scientist working with bird flu rushed through lab procedures in order to get to a staff meeting, setting off what could have been a fatal mishap, health officials said on Friday. They said the U.S. Centers for Disease Control and Prevention (CDC) lab worker, who was not identified, allotted only about half the time necessary to carry out the procedures safely, and as a result samples of mild avian flu were tainted with a highly deadly strain and sent from CDC to researchers at the U.S. Department of Agriculture. CDC released the report of its investigation of the avian flu incident and said disciplinary action is under consideration. CDC did not report the incident until July.
 
 

Report: CDC scientist kept quiet about flu blunder

 
‎15 ‎August ‎2014, ‏‎07:31:18 PMGo to full article
File picture of CDC Director Frieden on a monitor as he testifies before a hearing on Capitol Hill in WashingtonNEW YORK (AP) — A government scientist kept silent about a potentially dangerous lab blunder and revealed it only after workers in another lab noticed something fishy, according to an internal investigation.
 
 

Roche says US approves Avastin drug to treat cervical cancer

 
‎15 ‎August ‎2014, ‏‎02:37:13 PMGo to full article
The logo of Swiss pharmaceutical company Roche is seen outside the Shanghai Roche Pharmaceutical Co. Ltd. headquarters in ShanghaiZURICH (Reuters) - Swiss drugmaker Roche said on Friday the U.S. Food and Drug Administration (FDA) had approved the use of its Avastin cancer drug in combination with chemotherapy to treat advanced cervical cancer. Avastin has now been approved to treat five distinct tumor types in the United States, Roche said. (Reporting by Alice Baghdjian)
 
 

Pope prays for Korea ferry disaster victims, warns of spiritual 'cancer'

 
‎15 ‎August ‎2014, ‏‎06:38:59 AMGo to full article
Pope Francis gestures during a meeting with Asian youths at the Solmoe Shrine in DangjinBy Philip Pullella and Kahyun Yang DAEJEON South Korea (Reuters) - Pope Francis on Friday commemorated the more than 300 people killed in a ferry disaster in April, and called on South Koreans, among Asia's richest people, to beware of the spiritual "cancer" that often accompanies affluent societies. On the second day of his first trip to Asia, the pope met with families of victims and some survivors of the tragedy ahead of a Mass before about 50,000 people at the World Cup stadium in the central city of Daejeon. Lee Ho-Jin, the father of one of the victims, and who had been preparing to convert, asked the pope to be baptized into the Catholic Church. The pope said yes and the pontiff will perform the rite himself in Seoul on Saturday, a spokesman said.
 
 

Robin Williams' death highlights Parkinson's-depression link

 
‎15 ‎August ‎2014, ‏‎02:15:45 AMGo to full article
A woman takes a picture of a mural depicting late actor Robin Williams in BelgradeBy Piya Sinha-Roy and Eric Kelsey LOS ANGELES (Reuters) - Robin Williams was suffering from the early stages of Parkinson's disease along with severe depression at the time of his apparent suicide, his widow said on Thursday, drawing public attention to the correlation between the diseases. Although the gifted comedian had spoken before about his depression, Parkinson's experts have noted how the incurable and debilitating nervous system disorder that causes tremors and slowness of movement also affects people emotionally. "The neurochemicals that are impacted by Parkinson's disease and the pathways that control motor functions are also integrally involved in the control of mood," said Dr. Irene Richard, a neurology professor at the University of Rochester in New York. More than half of those who suffer from Parkinson's also experience clinical depression, according to the National Parkinson Foundation, which advises all Parkinson's patients to be screened for depression.
 
 

AstraZeneca starts final-stage tests on severe asthma drug

 
‎14 ‎August ‎2014, ‏‎05:42:40 PMGo to full article
A sign is seen at an AstraZeneca site in MacclesfieldAstraZeneca said on Thursday it was starting final-stage Phase III clinical trials for its experimental drug tralokinumab as a treatment for severe asthma. The drug, which showed promising results in mid-stage trials in May, was among those highlighted by AstraZeneca as part of its defense against an abortive $118 billion takeover bid by Pfizer. Like many of AstraZeneca's biggest new drug hopes, the medicine was developed by MedImmune, the U.S.-based biotech company acquired by AstraZeneca in 2007. Several firms are racing to develop injectable biotech asthma drugs for patients with severe disease who do not respond well to traditional inhalers, in pursuit of a new market worth a possible $7.5 billion a year.
 
 

Intel to use 'big data' to battle Parkinson's disease

 
‎14 ‎August ‎2014, ‏‎12:15:51 PMGo to full article
Anonymous patient data is aggregated and analyzed for new insight into Parkinson's disease via a new partnership between Intel and the Michael J. Fox Foundation.US computing giant Intel announced Wednesday it was joining an effort to battle Parkinson's disease with new big data and wearable technologies to improve research and treatment. Intel said it would work with the Michael J. Fox Foundation for Parkinson's Research -- created by the "Back to the Future" Canadian-American actor -- on the effort to fight the neurodegenerative brain disease second only to Alzheimer's in worldwide prevalence. The research will use "a new big data analytics platform that detects patterns in participant data collected from wearable technologies used to monitor symptoms," an Intel statement said. "Nearly 200 years after Parkinson's disease was first described by Dr James Parkinson in 1817, we are still subjectively measuring Parkinson's disease largely the same way doctors did then," said Todd Sherer, chief executive of the foundation.
 
 

Older people should get high dose flu shot: study

 
‎14 ‎August ‎2014, ‏‎11:32:10 AMGo to full article
Older people should get high dose flu shot: studyOlder people are likely to benefit from a high-dose flu vaccine to ward off the seasonal malaise, which can be particularly dangerous to those over 65, researchers said Wednesday. The findings in the New England Journal of Medicine are from the first randomized, controlled trial to compare high and standard doses of flu vaccine in older people. "Until this trial came out we didn't know if it was going to be clinically better or not, and now we know it is better," said lead author Keipp Talbot, assistant professor of medicine at Vanderbilt University. The study was funded by Sanofi Pasteur and compared the company's Fluzone High-Dose inactivated influenza vaccine to the standard-dose Fluzone vaccine.
 
 

Robin Williams masked depression with veil of comedy: friends

 
‎14 ‎August ‎2014, ‏‎01:39:43 AMGo to full article
Actor Williams pays tribute to actor Damon during 24th American Cinematheque Award benefit gala in Beverly HillsBy Piya Sinha-Roy LOS ANGELES (Reuters) - From an eccentric alien to an animated blue genie, a loveable British nanny and a fatherly therapist, actor Robin Williams used his multi-layered brand of comedy to make people laugh. While the Oscar-winner's death came as a bolt from the blue to the public, the actor's longtime friend and fellow comedian Bob Zmuda said he was not "totally shocked" by the news. Zmuda, the founder of the charity Comic Relief for which the actor had helped raise more than $70 million, said that Williams had difficulty connecting with people off-stage and that even those who knew him well were unaware of how severe his depression was. "That was his life blood, that was his psychological imperative, and without that, he was pretty lost." Budd Friedman, the founder of The Improv comedy clubs, last saw Williams about a year ago when the actor dropped by a club to perform a short routine.
 
 

Older people should get high dose flu shot

 
‎14 ‎August ‎2014, ‏‎01:03:35 AMGo to full article
A patient receives an influenza shot on January 6, 2014 in Fort Lauderdale, FloridaOlder people are likely to benefit from a high-dose flu vaccine to ward off the seasonal malaise, which can be particularly dangerous to those over 65, researchers said Wednesday. The findings in the New England Journal of Medicine are from the first randomized, controlled trial to compare high and standard doses of flu vaccine in older people. "Until this trial came out we didn't know if it was going to be clinically better or not, and now we know it is better," said lead author Keipp Talbot, assistant professor of medicine at Vanderbilt University. The study was funded by Sanofi Pasteur and compared the company's Fluzone High-Dose inactivated influenza vaccine to the standard-dose Fluzone vaccine.
 
 

Two out of five U.S. adults at risk of developing diabetes: study

 
‎14 ‎August ‎2014, ‏‎12:49:57 AMGo to full article
Two out of five U.S. adults born between 2000 and 2011 are expected to develop type 2 diabetes at some point in their life, which is double the rate for men and some 50 percent higher for women born two decades earlier, according to a new study. The lifetime risk of an American born between 2000 and 2011 developing the disease is roughly 40 percent for men and women, up from 20 percent for men and 27 percent for women between 1985 and 1989, the study said. "Soaring rates of diabetes since the late 1980s and longer overall life expectancy in the general population have been the main drivers of the striking increase in the lifetime risk of diabetes over the last 26 years," Dr. Edward Gregg, lead author and a chief of diabetes epidemiology and statistics at the U.S. Centers for Disease Control and Prevention, said in a statement. More than 29 million people in the United States are estimated to have diabetes, the overwhelming majority of them suffering from the type 2 variety.
 

U.S. FDA approves Merck insomnia drug

 
‎13 ‎August ‎2014, ‏‎11:28:36 PMGo to full article
By Toni Clarke WASHINGTON (Reuters) - The U.S. Food and Drug Administration said on Wednesday it has approved a new insomnia drug made by Merck & Co. The drug, to be called Belsomra, is the first in a new class of sedatives that block chemicals in the brain called orexins that help keep people awake. As a result, the FDA said, no more than one pill should be taken per night and the dose should not exceed 20 milligrams. The FDA had asked Merck to study the next-day driving performance of people who took the drug amid concerns the sedative could lead to next-day drowsiness. The test showed impaired driving in patients who took 20 milligrams of the drug.
 

Intel explores wearable devices for Parkinson's disease research

 
‎13 ‎August ‎2014, ‏‎10:05:39 PMGo to full article
A man walks past an Intel logo during a news conference by Intel Chief Executive Otellini in TaipeiBy Christina Farr SAN FRANCISCO (Reuters) - Intel Corp plans to use wearable gadgets such as smart watches to monitor patients with Parkinson's disease and collect data that can be shared with researchers. On Wednesday, the chip maker said it is teaming up with the Michael J. Fox Foundation, established by the actor and Parkinson's sufferer in 2000, to conduct a multi-phase research study of the neurodegenerative brain disease. An estimated five million people globally have been diagnosed with Parkinson's, the second-most-common neurudegenerative disease after Alzheimer's. The initial goal is to determine the feasibility of using wearable devices to monitor patients remotely and store that data in an open system that can be accessed by scientists. Participants will be monitored via an array of wearable devices.
 
 

How I Overcame Acute Anxiety and Crippling Depression

 
‎13 ‎August ‎2014, ‏‎06:26:17 PMGo to full article
As far as I can remember, I'd always been a very anxious child. I always had a million worries on my mind and overthought until I was so tightly trapped in my own mental webs I could no longer breathe. Perhaps this caused my chronic depression or only exacerbated it when I was left unable to enjoy the things I loved.I remember the anxiety...
 

Regular exercise after menopause tied to lower breast cancer risk

 
‎13 ‎August ‎2014, ‏‎06:07:36 PMGo to full article
By Kathryn Doyle NEW YORK (Reuters Health) - Middle aged women who get a few hours of activity each week, including walking or more vigorous exercise, are less likely to be diagnosed with breast cancer than more sedentary women, according to a new study from France. “The women who recently, in the previous four years, performed physical activity had a decreased risk of breast cancer compared with women who were not so active,” said coauthor Françoise Clavel-Chapelon. “We looked at recreational physical activity and even if it’s of modest intensity, let’s say, it had rapid impact on breast cancer risk,” Clavel-Chapelon, at the Institut Gustave-Roussy in Villejuif, told Reuters Health by phone. Of the 59,308 postmenopausal women followed between 1993 and 2005 in the study, most were teachers and 2,155 were diagnosed with invasive breast cancer.
 

Living With Cancer: A Year in the Clear

 
‎13 ‎August ‎2014, ‏‎04:31:01 PMGo to full article
Living With Cancer: A Year in the ClearPhoto credit: Justin Allbritten: Eloise, Harlan, Jennifer, Tristan -- July 2014 "The mystery of human existence lies not in just staying alive, but in finding something to live for." -- Fyodor Dostoyevsky, The Brothers KaramazovIn my day-to-day life I don't often dwell on the exact state of my cancer, but as my quarterly CT scan approaches I...
 
 

Two in five Americans at risk from type 2 diabetes

 
‎12 ‎August ‎2014, ‏‎11:27:01 PMGo to full article
A woman walks by a sign advertising sugary drinks in a Brooklyn neighborhood with a high rate of obesity and diabetes on June 11, 2013 in New York CityTwo in five American adults are expected to develop type 2 diabetes in their lifetime, according to a study published Tuesday that warned of spiralling health costs as a result. The risk was even higher for Hispanics and black women, half of whom are expected to develop the disease caused mainly by physical inactivity and excess bodyweight. The lifetime risk of developing type 2 diabetes, also known as adult-onset or non-insulin dependent diabetes, rose from 20 percent for men and 27 percent for women in 1985-1989 to 40 percent for men and 39 percent for women in 2000-2011, researchers found. "The largest increases were in Hispanic men and women, and non-Hispanic black women, for whom lifetime risk now exceeds 50 percent," according to the authors of the study in The Lancet medical journal.
 
 

French drugmaker delivers first semi-synthetic malaria drugs

 
‎12 ‎August ‎2014, ‏‎11:15:38 PMGo to full article
Logo of French pharmaceutical group Sanofi taken on September 25, 2012 in ParisFrench pharmaceutical giant Sanofi announced Tuesday the delivery of the first anti-malaria drugs using a semi-synthetic version of their key ingredient to millions of patients in Africa. Sanofi said that the development of semi-synthetic artemisinin -- the weapon of choise against malaria -- signalled a "new era" in the fight against the mosquito-borne disease. The World Health Organization gave the use of semi-synthetic artemisinin in malaria products the green light in May last year. Sanofi said that "by complementing botanically-derived supplies, the new option can widen access to treatment for millions sickened by malaria every year."
 
 

Health Q&A: The answer to preventing heart disease is diet

 
‎12 ‎August ‎2014, ‏‎10:35:19 PMGo to full article
On preventing heart disease and avoiding diabetic amputations
 

Pfizer to help 23andMe unravel genetic ties to bowel disease

 
‎12 ‎August ‎2014, ‏‎07:59:29 PMGo to full article
The Pfizer logo is seen at their world headquarters in New YorkHome genetics company 23andMe on Tuesday said it hopes to uncover gene mutations linked to inflammatory bowel disease (IBD) by enrolling 10,000 people with the hard-to-treat malady and examining DNA from their donated saliva samples. The privately held company, founded in 2006 by Anne Wojcicki and backed by Google Inc, said U.S. drugmaker Pfizer Inc will support its latest research effort. "We're hoping within a year or two to have some meaningful genetic data and that it might lead to either an improved therapy or a new therapy for IBD," said Catherine Afarian, a spokeswoman for 23andMe, which is based in Mountain View, California.
 
 

For older colon cancer survivors, colonoscopies carry risks: study

 
‎12 ‎August ‎2014, ‏‎06:05:26 PMGo to full article
By Kathryn Doyle NEW YORK (Reuters Health) - After age 75, recurrences of colon cancer are rare and the risks of repeated colonoscopies may outweigh the benefits, according to new research. “Our study was different in that we specifically examined patients that were undergoing surveillance examinations because of a previous history of colonic polyps or cancer,” said lead author Dr. An Hong Tran of Kaiser Permanente Los Angeles Medical Center in California. “We found that recurrent colorectal cancer in this population was significantly less likely after age 75,” Tran said. “We also found that the risk of post-procedure hospitalization following a surveillance colonoscopy increased significantly after age 75 compared to younger patients, even after adjusting for the effects of chronic illnesses.” People with colorectal cancer or high-risk polyps usually undergo repeat colonoscopies every few years to make sure the disease hasn't recurred.
 

Why Cancer Divorce Is Necessary for Survival

 
‎11 ‎August ‎2014, ‏‎10:33:31 PMGo to full article
Why Cancer Divorce Is Necessary for SurvivalDear Cancer,It's you, not me. I'm making a conscious choice to break up with you. You think you can drag me out of bed at any given time and mess with my sleep schedule. You demand the right to pull out my hair. You've done your best to distance me from my friends and family. You want to control my everyday actions and thoughts and demand I...
 
 

University Cancer and Blood Center chemotherapy treatments at Winder office

 
‎11 ‎August ‎2014, ‏‎03:47:19 PMGo to full article
University Cancer and Blood Center now provides chemotherapy treatments to patient's at its Winder office located at 20 Satellite Drive, Suite 200. For more information, visit www.universitycancer.
 

Toronto-area hospital treating Nigeria traveler with flu-like symptoms : TV

 
‎09 ‎August ‎2014, ‏‎01:19:43 AMGo to full article
TORONTO (Reuters) - A Toronto-area hospital is treating a patient with fever and flu-like symptoms who recently visited Nigeria, where a state of emergency has been declared over the Ebola outbreak in West Africa. CBC News said on Friday that the patient has been isolated at the Brampton, Ontario hospital, as a precautionary measure. The World Health Organization (WHO) said on Friday that West Africa's Ebola epidemic constituted an international health emergency and the virus, which has killed nearly 1,000 people, could continue spreading for months. ...
 

National Academy of Sciences agrees with EPA that formaldehyde causes cancer

 
‎08 ‎August ‎2014, ‏‎10:11:25 PMGo to full article
To the chemical industry's chagrin, a National Academy of Sciences review found that formaldehyde causes cancer.
 

Diabetes drug could increase lifespan: study

 
‎08 ‎August ‎2014, ‏‎05:43:41 PMGo to full article
Diabetes drug could increase lifespan: studyA large-scale study conducted by researchers at Cardiff University says that type 2 diabetes patients live longer than people without the disease thanks to surprising benefits of their medication, metformin, which could be expanded for use in non-diabetics. Murmurs of metformin's attributes had been circulating within the scientific community, and the findings of the Cardiff study not only build on its benefits but are of particular interest due to the massive sample size of 180,000 participants. Researchers compared survival rates of type 2 diabetes patients taking metformin, a first-line therapy, with those of patients on a less-prescribed diabetes drug called sulphonylurea, known for undesirable side effects such as weight gain and hypoglycemia. "What we found was illuminating," said lead author Professor Craig Currie from Cardiff University's School of Medicine.
 
 

British body rejects new Roche breast cancer drug over price

 
‎08 ‎August ‎2014, ‏‎09:39:27 AMGo to full article
A new drug from Roche for women with an incurable form of breast cancer is too expensive for routine use on Britain's state-run health service even after a discount, the country's healthcare cost watchdog ruled on Friday. The National Institute for Health and Clinical Excellence (NICE) said it was "disappointed" Roche had decided against offering Kadcyla at a price that would make it affordable for routine use on the National Health Service (NHS). NICE, which is responsible for deciding if drugs should be used on the NHS, originally called for Roche to reduce the price of Kadcyla in April. This second rebuff forms part of a growing debate among healthcare authorities in Europe about the high price of modern medicines, especially those for treating cancer.
 

Diabetes-related amputations more common in poor areas

 
‎07 ‎August ‎2014, ‏‎11:29:31 PMGo to full article
By Andrew M. Seaman NEW YORK (Reuters Health) - People with diabetes who live in the poorest areas of California are about twice as likely to end up with their legs or feet amputated than those living in the wealthiest areas, according to a new study. Black people and those who spoke Spanish appeared to be at a considerable disadvantage when it came to the likelihood of diabetes-related amputations, the researchers found. “I think our findings show that the medical safety net has big holes in it and people are often falling through those holes and losing their limbs to diabetes when those complications could have been prevented with better care,” Dr. Carl D. Stevens said. He and his colleagues write in the journal Health Affairs that in past studies, low-income people with diabetes tended to receive worse care for their disease, but no study had looked at overall poverty and amputations of legs and feet.
 

Swiss researchers see arthritis cure in mice

 
‎07 ‎August ‎2014, ‏‎10:19:03 PMGo to full article
Swiss researchers say they have taken an important step towards a cure for arthritis, successfully testing a prototype treatment in mice that may soon be trialled on humansSwiss researchers say they have taken an important step towards a cure for arthritis, successfully testing a prototype treatment in mice that may soon be trialled on humans. The experimental drug "fully cured" arthritic mice who had hobbled on inflamed and swollen toes and paws, scientists at the Swiss Federal Institute of Technology in Zurich (ETHZ) said. Rheumatoid arthritis is a condition that causes painful inflammation of joints, sometimes destroying cartilage and bone as it progresses. The disease affects up to one percent of the world's population, according to ETHZ, but while various drugs are used to stop or slow the progression of the disease, there has until now been no known cure.
 
 

High fruit and veggie diet linked to lower risk of heart disease, death

 
‎07 ‎August ‎2014, ‏‎09:13:57 PMGo to full article
By Kathryn Doyle NEW YORK (Reuters Health) - Researchers have more evidence linking a diet with lots of fruits and vegetables to better health outcomes. The idea that fruits and veggies are good for you isn't new, of course. What’s new in this study is that researchers saw a dose-response relationship: the more fruits and veggies people ate, the less likely they were to have heart problems or die while researchers were studying them. The protective effects of fruits and veggies leveled out at five servings per day, which supports current dietary recommendations, senior author Dr. Frank B. Hu, of the departments of nutrition and epidemiology at the Harvard School of Public Health in Boston, told Reuters Health by email.
 

Gastrointestinal Health and Cancer Prevention

 
‎07 ‎August ‎2014, ‏‎08:40:00 PMGo to full article
Michelle Kang Kim, MD, MScAssociate Director of Endoscopy, Mount Sinai HospitalAssistant Professor of Medicine, Icahn School of Medicine at Mount SinaiGastrointestinal cancers occur in the digestive system, including both the upper and lower digestive tracts. Older people and those with a strong family history -- a parent or first-degree...
 

Study ties new gene to major breast cancer risk

 
‎07 ‎August ‎2014, ‏‎06:54:25 AMGo to full article
It's long been known that faulty BRCA genes greatly raise the risk for breast cancer. Now scientists say a more recently identified, less common gene can do the same.
 

New breast cancer gene mutation found to raise risk

 
‎06 ‎August ‎2014, ‏‎11:49:59 PMGo to full article
A woman gets a mammogram to screen for breast cancer on May 15, 2001 in Putanges, FranceA newly discovered gene mutation significantly raises a woman's risk of breast cancer and may be considered the third such inherited gene flaw known to science, researchers said Wednesday. Women with mutations in the PALB2 gene face a one in three chance of getting breast cancer by age 70, said the findings in the New England Journal of Medicine. The other two known gene mutations associated with breast cancer risk, BRCA1 and BRCA2, have been linked to a 55-65 percent likelihood of developing breast cancer by age 70. "Since the BRCA1 and BRCA2 mutations were discovered in the mid-90s, no other genes of similar importance have been found and the consensus in the scientific community if more exist we would have found them by now," said lead author Marc Tischkowitz from the Department of Medical Genetics at the University of Cambridge.
 
 

Experimental non-invasive tests detect rare brain disease

 
‎06 ‎August ‎2014, ‏‎11:05:29 PMGo to full article
By Gene Emery NEW YORK (Reuters Health) - An analysis of two experimental tests for Creutzfeldt-Jakob disease shows that cells in the nose or a urine sample can detect versions of the brain-destroying illness. The urine test proved effective at identifying the human form of mad cow disease. The research, reported in the New England Journal of Medicine, may make it far easier to diagnose the illness, track its progress in the body and evaluate potential treatments. "That would help us in our diagnosis, and we wouldn't have to do invasive procedures.
 

Study finds a gene mutation increases breast cancer risk to 1 in 3

 
‎06 ‎August ‎2014, ‏‎11:03:55 PMGo to full article
By Kate Kelland LONDON (Reuters) - Women with mutations in a gene called PALB2 have a one in three chance of developing breast cancer by age 70, according to research that suggests PALB2 is almost as important a risk factor as BRCA1 or BRCA2 mutations. BRCA1 and BRCA2 are widely known as breast cancer risk genes. Last year, actress Angelina Jolie went public with her decision to undergo prophylactic mastectomy after she tested positive for a BRCA mutation. Mutations in the same genes also increase the risk of ovarian cancer.
 

New York teen wins $50,000 prize for invention aiding Alzheimer's patients

 
‎06 ‎August ‎2014, ‏‎10:03:54 PMGo to full article
A New York teenager whose grandfather suffers from Alzheimer's disease won a $50,000 science prize for developing wearable sensors that send mobile alerts when a dementia patient begins to wander away from bed, officials said on Wednesday. Kenneth Shinozuka, 15, who took home the Scientific American Science in Action Award, said his invention was inspired by his grandfather's symptoms, which frequently caused him to wander from bed in the middle of the night and hurt himself. "I will never forget how deeply moved my entire family was when they first witnessed my sensor detecting Grandfather's wandering," Shinozuka said in a statement. "At that moment, I was struck by the power of technology to change lives." His invention uses coin-sized wireless sensors that are worn on the feet of a potential wanderer.
 

Ukraine restricts pig imports over disease fears

 
‎06 ‎August ‎2014, ‏‎05:36:23 PMGo to full article
Ukraine has introduced emergency restrictions on the import of pigs and pork products from nine countries including Poland, Russia, China and the United States, it said in documents filed at the World Trade Organization on Wednesday. Ukraine said porcine epidemic diarrhea had been identified in Canada, China, Columbia, Dominican Republic, Japan, Mexico and the United States, so it was temporarily banning their exports of live pigs and feed produced from pork products. The restriction came into force on July 25, Ukraine said. It put a restriction on the same products from Russia from July 21 after an outbreak affected the regions of Bryansk, Orenburg and Kursk, Ukraine's document said.
 

Roche says Avastin approved in EU for type of ovarian cancer

 
‎06 ‎August ‎2014, ‏‎01:30:11 PMGo to full article
The logo of Swiss pharmaceutical company Roche is seen outside their headquarters in BaselZURICH (Reuters) - Roche said on Wednesday that European regulators approved its drug Avastin as a treatment for women with ovarian cancer that is resistant to platinum-containing chemotherapy. Avastin, which is already approved in Europe to treat advanced stages of breast cancer, colorectal cancer, non-small cell lung cancer, kidney cancer and ovarian cancer, was the Basel-based drugmaker's biggest seller last year with sales of 6.25 billion Swiss francs ($6.9 billion). ...
 
 

Scientific review finds aspirin significantly cuts cancer rates

 
‎06 ‎August ‎2014, ‏‎01:06:55 AMGo to full article
By Kate Kelland LONDON (Reuters) - Taking a small daily dose of aspirin can significantly reduce the risk of developing - or dying from - bowel, stomach and oesophageal cancer, according to a large review of scientific studies. Researchers who analyzed all available evidence from studies and clinical trials assessing benefits and harm found that taking aspirin for 10 years could cut bowel cancer cases by around 35 percent and deaths from the disease by 40 percent. Rates of oesophageal and stomach cancer were cut by 30 percent and deaths from these cancers by 35 to 50 percent. Professor Jack Cuzick, head of the center for cancer prevention at Queen Mary University of London, said the evidence showed that, to reap the benefits of aspirin, people need to take a daily dose of 75 to 100 milligrams for at least five years and probably up to 10 years between the ages of 50 and 65.
 

Doctors on Call: Preventing asthma symptoms can allow for a better school year

 
‎05 ‎August ‎2014, ‏‎10:44:32 PMGo to full article
About 10 percent of children have asthma and, when poorly controlled, it can lead to persistent symptoms, school absences and potentially life-threatening flare-ups that might require emergency room visits.
 

Computer games may ease elderly depression: study

 
‎05 ‎August ‎2014, ‏‎06:00:59 PMGo to full article
People look at a screen which shows the Xbox One logo during a presentation of the Xbox One in Shanghai, on July 30, 2014Brain-boosting computer games may be as effective as drugs in treating severe depression in some elderly people -- perhaps even better, according to trial results published on Tuesday. A group of 60-to-89-year-olds, for whom anti-depressants had not worked, perked up after four weeks of playing computer games that had been developed to improve brain fitness, scientists wrote in the journal Nature Communications. The programmes were developed to test a theory that the ageing brain can be regenerated through intense practice -- regaining lost learning and memory function and improving decision-making, which can in turn alleviate depression. A team of specialists from the United States and China put 11 people through a four-week computer training programme, and tested them for improvements in depression levels and in brain function.
 
 

HIV may help prevent multiple sclerosis

 
‎05 ‎August ‎2014, ‏‎12:54:16 AMGo to full article
A view of an interactive display at the American Museum of Natural History in New York, November 16, 2010Scientists said on Monday they had statistical evidence to back a novel theory that infection by the AIDS virus may reduce the risk of multiple sclerosis (MS). Patients in England who were infected with the human immunodeficiency virus (HIV) were mathematically far less likely to develop MS than the general population they found. MS is a progressive disease of the brain and central nervous system in which the immune system goes haywire, attacking a fatty insulative sheath around nerve fibres. In 2011, doctors reported on the case of a 26-year-old Australian man who was diagnosed with MS several months after being confirmed as having HIV.
 
 

Amgen blood cancer drug succeeds in late-stage study

 
‎04 ‎August ‎2014, ‏‎02:56:38 PMGo to full article
The Amgen corporate logo is seen at the company's office in South San Francisco(Reuters) - Amgen Inc said a late-stage study found that its blood cancer drug helped patients live significantly longer without the disease worsening, compared with standard treatment. The world's largest biotechnology company's shares rose as much as 4.3 percent to $131.00 in premarket trading, after it released interim data for its injectable drug, Kyprolis. The U.S. Food and Drug Administration, in 2012, granted the drug accelerated approval for use in multiple myeloma, the second most common form of blood cancer. Accelerated approval is granted to drugs for serious diseases with little or no treatment options, based on data from initial trials.
 
 

Ailing 'Ghostbusters' artist gives bird to cancer

 
‎04 ‎August ‎2014, ‏‎09:15:38 AMGo to full article
In this July 16, 2014 photo, artist Michael Gross, who is battling cancer, sits in his studio between one of his paintings and one of his photos on his computer screen in Oceanside, Calif. Gross has decided to use his art and the work of other artist to raise money in his fight against cancer. (AP Photo/Lenny Ignelzi)LOS ANGELES (AP) — Michael Gross never planned on joining the front lines of the fight against cancer.
 
 

Alzheimer's rate higher in parts of SD

 
‎03 ‎August ‎2014, ‏‎10:12:00 PMGo to full article
County report finds rate greater in La Mesa, National City and Chula Vista.
 

Ebola distracts from worsening Cameroon cholera outbreak

 
‎02 ‎August ‎2014, ‏‎04:32:55 PMGo to full article
By Misha Hussain and Tansa Musa DAKAR/YAOUNDE (Thomson Reuters Foundation) - A cholera epidemic in northern Cameroon has killed at least 65 people and probably infected about 1,300 people in two months, as international attention has been diverted to fighting Ebola in West Africa, health experts said on Saturday. They said the insurgency by Islamist sect Boko Haram was also hampering efforts to control the outbreak. Atilio Rivera-Vasquez, public health adviser in the region for International Medical Corps, said Cameroonian health authorities were diverting resources to impose checks at border crossing and airports for Ebola, after it killed more than 700 people in Guinea, Sierra Leone and Liberia. “This is distracting from an appropriate and fast response to this cholera epidemic,” Rivera-Vasquez said.
 

Biota's flu drug fails mid-stage study

 
‎01 ‎August ‎2014, ‏‎01:46:16 PMGo to full article
(Reuters) - Biota Pharmaceuticals Inc said its experimental influenza drug failed to meet the main goal in a mid-stage study. Patients given a 40 milligram (mg) or 80 mg dose did not achieve a statistically significant reduction, compared with the placebo, in the median time to alleviate influenza symptoms - the main goal of the trial, Biota said. The U.S. Department of Health and Human Services in April pulled out of a contract to support the drug's development with $231 million, after which the company said it would stop work on the drug. Biota said in June it would cut its workforce by about two-thirds and shut a facility in Melbourne, Australia following the loss of the contract.

 

 

 

Weathering the Coming Storm


 

 

 

Price R399.00

 

 


 

Description

Dr. Chuck Missler, an internationally known business executive, outlines our current economic predicament and defensive steps you can take to lessen the impact of the impending economic crisis. As a Bible teacher for over 30 years with a ministry reaching over 40 countries, Chuck shares some key strategies to prepare yourself spiritually and practically.

Is the World facing another major economic upheaval?

What is the best strategy to protect your family in times of economic uncertainty?

The Church has enjoyed a relatively peaceful existence in the West for a few centuries but the with the coming persecution, how do we go about organizing home study and home-church?

Soul Survival – Keeping your “lamp full” during the hard times ahead.

Join Dr. Chuck Missler and Ron Matsen in the Executive Brie fing Room of
The River Lodge, New Zealand, in an intensive summary outlining what lies
ahead and how we can prepare for the coming storm.

Runtime: Approx. 5 hours

© 2012 Koinonia House Inc.

Available in the following formats:

 

DVD:

•3 Disks
•5 M4A Files
•1 PDF Notes File
•Color, 16:9, Dolby Digital 2.0 stereo, Region encoding (This DVD will be viewable in other countries WITH the proper DVD player and television set.)


 

*** New Release ***

Expectations

 of the

 Antichrist

 

 

Dr. Chuck Missler and Ron Matsen

 

Price R 499.00

 

There are many diverse anticipations concerning the Coming World Leader, commonly referred to as “The Antichrist.” This study will explore the Biblical descriptions with the specific expectations of the globalists, Islam, the Vatican, Freemasonry, and others.
• Will he be a Nephilim?
• Why is the Vatican openly preparing to receive an “alien” visitor?
• Will he be a resurrection of Nimrod? Is his DNA a factor?
• What are the expectations of transhumanist technologists in this regard?
Clearly, the Bible has much more to illuminate this issue far beyond the popular conceptions; and yet the composite perspective will astonish most. Furthermore, is there a climactic cosmic deception being prepared that, if it were possible, “it would deceive the very elect”? Jesus commanded us, “Be not deceived.” But, how?
How close are these events to our current horizon?
Join Dr. Chuck Missler and Ron Matsen in an intensive summary of some of the Strategic Trends that will impact all of us.
Available in the following formats:

DVD:
•3 Discs
•6 M4A Files
•1 PDF Notes File
•Color, Fullscreen 16:9, Dolby Digital 2.0 stereo, Region  encoding ( This DVD will be viewable in other countries WITH the proper DVD player and television set.)


 

 

 

Feed image

Featured Video

End the Shame. End the Isolation. End Fistula.

 

 

 

 

***Brand New Release***

 

Beginning of Wisdom

by

 Dr. Chuck Missler


“The fear of God is the beginning of wisdom.” Proverbs 9:10

But how do we balance the awesome majesty due to the Creator and Ruler of the universe with the gracious family intimacy that is now available to us through the completed work of Christ?

What does His Holiness demand of us, personally?

What are the hazards of failing to render the Almighty His due, while availing ourselves the riches committed to us of the precious promises in His Word?

How do we deal with these paramount issues facing us daily in practical challenges?

Chuck Missler grapples with these wildly misunderstood tensions with down-to-earth frankness and Biblically-based candor.
 

Price R 179

 
 

 

Hal Lindsey Report:

 

THE REAL ISSUE

SAME SEX MARRIAGE

 

Genetically Modified Food & People.

 

 

 

Go Live           Link

 

*** New Release ***

 Angels, Volume III:

The Denizens of the Metacosm

 

DVD

 

 

Price R 179.00

 

Angels, Volume III: The Denizens of the Metacosm

 

DVD

by Dr. Chuck Missler

 

Description

Volumes 1 & 2 of this series explored the finite limits and boundaries of our physical reality. After probing the limits of both the Macrocosm and the Microcosm, we discovered that our reality is but a shadow of larger reality, the Metacosm, a domain of extra-dimensional transfers and other paradoxical phenomena.

 

Volume 3 explores the contradictory behavior of UFOs and other demonic deceptions characteristic of the End Times. Explore these topics in more detail in either this two-hour briefing, Angels Vol 3: The Denizens of the Metacosm or our six-hour extensive study, Expectations of the Antichrist.

 

 

• Are they real?

• Why do UFOs enjoy a military classification higher than our most sensitive weapons systems?

• Why are the events which occurred in Roswell New Mexico still classified after 66 years?

• Why is the Vatican openly preparing to receive an Alien Visitor?

• How should a Christian deal with the occurrences of Alien abductions?

• Jesus admonished us to “Be not deceived.” How?

• How do we prepare for the deception which, “if it were possible, would deceive the very elect”?

 

Join Dr. Chuck Missler in the Executive Briefing Room of the River Lodge, New Zealand, exploring the misinformation, (and deliberate disinformation) about the various “denizens of the Metacosm” and other insights of the invisible war unfolding on our near horizon.

 

This briefing pack contains 2 hours of teaching

 

Available in the following formats

 

DVD:

•1 Disc

•2 M4A Files

•Color, Fullscreen 16:9, Dolby Digital 2.0 stereo, Region. This DVD will be viewable in other countries WITH the proper DVD player and television set.)

 

DVD

PRICE  R 159.00

DVD

PRICE R 159.00

 

DVD

Price  R 159.00

 

DVD

Price R 159.00

 

 

 

 

 

 

 

 

 

 

 

 


Global Events Disaster Site


Extreme Weather, Epidemic, Terror Attack, Biological Hazard,

Volcano Eruption, Earthquake, Incidents at Sea

 

 

"In seasons of severe trial, the Christian has nothing on earth that he can trust to, and is therefore compelled to cast himself on God alone. When no human deliverance can avail, he must simply and entirely trust himself to the providence and care of God. Happy storm that wrecks a man on such a rock as this! O blessed hurricane that drives the soul to God--and God alone!"
- Spurgeon

 

 

 

***SPECIAL OFFER ***

The Hybrid Age  

BUY THE DVD

&

GET THE BOOK

 

ONLY

PRICE R199.00

THIS LINK ONLY

 

 

The Hybrid Age  


by Tom Horn and Chuck Missler

 
 
 
Price R 159.00
 
 

***In Stock ***

Forbidden Gates: How Genetics, Robotics, Artificial Intelligence, Synthetic Biology, Nanotechnology, and Human Enhancement Herald The Dawn Of TechnoDimensional Spiritual Warfare.
THE BOOK

 

Price R179.00

 

 

Book

While Forbidden Gates includes fresh insights for traditional, tried and true methods of overcoming darkness, it also unveils for the first time how breakthrough advances in science, technology, and philosophy—including cybernetics, bio-engineering, nanotechnology, machine intelligence, synthetic biology, and transhumanism—will combine to create mind-boggling game-changes to everything you have ever known about spiritual warfare.

In recent years, astonishing technological developments have pushed the frontiers of humanity toward far-reaching morphological transformation that promises in the very near future to redefine what it means to be human. An international, intellectual and fast-growing cultural movement known as transhumanism intends the use of genetics, robotics, artificial intelligence and nanotechnology (GRIN technologies) as tools that will radically redesign our minds, our memories, our physiology, our offspring, and even perhaps, as Joel Garreau in his bestselling book Radical Evolution claims, our very souls. The technological, cultural, and metaphysical shift now under way unapologetically forecasts a future dominated by this new species of unrecognizably superior humans, and applications under study now to make this dream reality are being funded by thousands of government and private research facilities around the world. As the reader will learn, this includes among other things rewriting human DNA and combining men with beasts, a fact that some university studies and transhumanists believe will not only alter our bodies and souls but could ultimately open a door to contact with unseen intelligence.

As a result, new modes of perception between things visible and invisible are expected to challenge the Church in ways that are historically and theologically unprecedented. Without comprehending what is quickly approaching in related disciplines of research and development, vast numbers of believers could be paralyzed by the most fantastic—and most far reaching—supernatural implications. The destiny of each individual—as well as the future of their family—will depend on their knowledge of the new paradigm and their preparedness to face it head on.

303 Pages


 

 

 

 

 

+27 11 969 0086


frosty@khouseafrica.com   

 

 

 

 

 

 

 

 

 

 

 

 

 


Bible

DVD

+

MP3 on CD-ROM
Featured Commentaries

Learn the Bible

 in 24 hours



Old Testament


Genesis

Exodus

Leviticus

Numbers

Deuteronomy

Joshua and The Twelve Tribes

Judges

Ruth and Esther

I and II Samuel

I and II Kings

I and II Chronicles

Ezra & Nehemiah

Job

Psalms

Proverbs

Ecclesiastes

Song of Songs

Isaiah

Jeremiah

/Lamentations

Ezekiel

Daniel

Hosea

Joel and Amos

Jonah, Nahum & Obadiah

Micah

Zechariah

The Minor

Prophets

 



New Testament


Matthew

Mark

Luke

John

Acts

Romans

I & II Corinthians

Galatians

Ephesians

Philippians

Colossians and Philemon

I and II

Thessalonians

Timothy/

Titus/Philemon

Hebrews

James

I and II Peter

I, II, and III John

Jude

Revelation

 


 

 

 

 

                                   2